Hani Alturkmani

Researcher

UAMS

Also affiliated: National Institutes of Health (2014); Alfaisal University (2012–2013); University of Arkansas Medical Center (2023); Truman Medical Center (2020); University of Mississippi Medical Center (2012); University of Illinois Chicago (2021); Central Arkansas Veterans Healthcare System (2022); Baptist Health Foundation (2022–2023); University of Kansas Medical Center (2015–2016); Saint Luke's Hospital (2017); National Institute on Deafness and Other Communication Disorders (2014); University of Missouri–Kansas City (2016–2020)

Faculty Researcher

11 h-index 36 pubs 466 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Hani Alturkmani's research focuses on cardiovascular conditions and bleeding disorders. He has conducted systematic reviews and meta-analyses on outcomes in patients with suspected pulmonary embolism and on the gynecologic, obstetric, and surgical management of women with von Willebrand disease. His work also investigates the safety and efficacy of anticoagulants like enoxaparin during percutaneous coronary interventions. Alturkmani has explored the application of machine learning in cardiovascular risk prediction and precision preventive approaches. He has also authored case reports on conditions such as severely calcified pericardium causing constrictive pericarditis and late-onset left atrial appendage occlusion device-related thrombus. Alturkmani's scholarship includes 36 publications, with an h-index of 11 and 458 total citations.

Metrics

h-index: 11
Publications: 36
Citations: 466

Selected Publications

Late-onset left atrial appendage occlusion device–related thrombus attributed to mitral bioprosthetic stenosis: a case report (2024)

European Heart Journal - Case Reports 2 citations DOI OpenAlex
Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)

Cardiovascular revascularization medicine DOI OpenAlex
Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention (2024)

The American Journal of Cardiology 2 citations DOI OpenAlex
100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)

JACC: Cardiovascular Interventions DOI OpenAlex
A case report of a rapidly growing giant coronary pseudoaneurysm: challenges and lessons learned (2023)

European Heart Journal - Case Reports 1 citation DOI OpenAlex
Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches (2023)

Current Atherosclerosis Reports 32 citations DOI OpenAlex
TUBERCULOSIS CARDIOMYOPATHY WITH A LEFT VENTRICULAR ANEURYSM AND THROMBUS (2023)

Journal of the American College of Cardiology DOI OpenAlex
HEARTMATE III IMPLANTATION IN SITUS INVERSUS TOTALIS (2023)

Journal of the American College of Cardiology DOI OpenAlex
Severely Calcified Pericardium Causing Constrictive Pericarditis (2023)

Methodist DeBakey Cardiovascular Journal 3 citations DOI OpenAlex
Percutaneous Management of Bioprosthetic Mitral Valve Dehiscence with Combined Valve-in-Valve Replacement and Paravalvular Leak Closure (2022)

Methodist DeBakey Cardiovascular Journal DOI OpenAlex
SEVERELY CALCIFIED PERICARDIUM CAUSING CONSTRICTIVE PERICARDITIS (2022)

Journal of the American College of Cardiology DOI OpenAlex
Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature (2021)

Blood Advances 32 citations DOI OpenAlex
Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature (2021)

Blood Advances 20 citations DOI OpenAlex